The DOI matches its Crossref record, with a small difference in title or year; 24 of the 25 references it cites were found in a registry or an index.
d -Dimer Testing to Determine the Duration of Anticoagulation Therapy
Open accessAbstract
BACKGROUND: The optimal duration of oral anticoagulation in patients with idiopathic venous thromboembolism is uncertain. Testing of D-dimer levels may play a role in the assessment of the need for prolonged anticoagulation. METHODS: We performed D-dimer testing 1 month after the discontinuation of anticoagulation in patients with a first unprovoked proximal deep-vein thrombosis or pulmonary embolism who had received a vitamin K antagonist for at least 3 months. Patients with a normal D-dimer level did not resume anticoagulation, whereas those with an abnormal D-dimer level were randomly assigned either to resume or to discontinue treatment. The study outcome was the composite of recurrent venous thromboembolism and major bleeding during an average follow-up of 1.4 years. RESULTS: The D-dimer assay was abnormal in 223 of 608 patients (36.7%). A total of 18 events occurred among the 120 patients who stopped anticoagulation (15.0%), as compared with 3 events among the 103 patients who resumed anticoagulation (2.9%), for an adjusted hazard ratio of 4.26 (95% confidence interval [CI], 1.23 to 14.6; P=0.02). Thromboembolism recurred in 24 of 385 patients with a normal D-dimer level (6.2%). Among patients who stopped anticoagulation, the adjusted hazard ratio for recurrent thromboembolism among those with an abnormal D-dimer level, as compared with those with a normal D-dimer level, was 2.27 (95% CI, 1.15 to 4.46; P=0.02). CONCLUSIONS: Patients with an abnormal D-dimer level 1 month after the discontinuation of anticoagulation have a significant incidence of recurrent venous thromboembolism, which is reduced by the resumption of anticoagulation. The optimal course of anticoagulation in patients with a normal D-dimer level has not been clearly established. (ClinicalTrials.gov number, NCT00264277 [ClinicalTrials.gov].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Self-citationKearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Kearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
Agnelli, G., Prandoni, P., Santamaria, M. G., Bagatella, P., Iorio, A., Bazzan, M., Moia, M., Guazzaloca, G., Bertoldi, A., Tomasi, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450302 · Cited by 591
Self-citationO'Neill, D. D., Westerman, D. P., & Sacco, W. (1966) · doi:10.21236/ad0635168 · Cited by 566
Pinede, L., Ninet, J., Duhaut, P., Chabaud, S., Demolombe-Rague, S., Durieu, I., Nony, P., Sanson, C., & Boissel, J.-P. (2001) · Circulation · doi:10.1161/01.cir.103.20.2453 · Cited by 408
Research works printed but not linked: 1
- Kearon C, 2003, CMAJ, 168, 183
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
“Consistent with frequency of major bleeding during prospective studies of extended anticoagulation for VTE (Table 6 in AT9(1)).(64,65,80,189,221)”
Background2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., Bengel, F., Brady, A. J. B., Ferreira, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn310 · Cited by 2,826
Jaff, M. R., McMurtry, M. S., Archer, S. L., Cushman, M., Goldenberg, N., Goldhaber, S. Z., Jenkins, J. S., Kline, J. A., Michaels, A. D., Thistlethwaite, P., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214914f · Cited by 2,229
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Saposnik, G., Barinagarrementeria, F., Brown, R. D., Bushnell, C. D., Cucchiara, B., Cushman, M., deVeber, G., Ferro, J. M., & Tsai, F. Y. (2011) · Stroke · doi:10.1161/str.0b013e31820a8364 · Cited by 1,970
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
Pulmonary embolism and deep vein thrombosis
Goldhaber, S. Z., & Bounameaux, H. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61904-1 · Cited by 1,054
Deep vein thrombosis and pulmonary embolism
Di Nisio, M., van Es, N., & Büller, H. R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30514-1 · Cited by 994
Tapson, V. F. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072753 · Cited by 1,024
Palareti, G., Legnani, C., Cosmi, B., Antonucci, E., Erba, N., Poli, D., Testa, S., Tosetto, A., & the DULCIS (D‐dimer‐ULtrasonography in Combination Italian Study) Investigators (See Appendix) (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12426 · Cited by 902
“A post hoc analysis [9] of the results of the Prolong study [3]found that the proportion of patients with positive D-dimer was much higher in patients aged ≥70 years (54.”
Self-citationLyman, G. H., Carrier, M., Ay, C., Di Nisio, M., Hicks, L. K., Khorana, A. A., Leavitt, A. D., Lee, A. Y. Y., Macbeth, F., Morgan, R. L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003442 · Cited by 893
Kakkos, S. K., Gohel, M., Baekgaard, N., Bauersachs, R., Bellmunt-Montoya, S., Black, S. A., ten Cate-Hoek, A. J., Elalamy, I., Enzmann, F. K., Geroulakos, G., et al. (2021) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2020.09.023 · Cited by 743
Prediction of venous thromboembolism in cancer patients
Ay, C., Dunkler, D., Marosi, C., Chiriac, A.-L., Vormittag, R., Simanek, R., Quehenberger, P., Zielinski, C., & Pabinger, I. (2010) · Blood · doi:10.1182/blood-2010-02-270116 · Cited by 772
The Epidemiology of Venous Thromboembolism in the Community
Heit, J. A. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.162545 · Cited by 778
Epidemiology and Risk Factors for Venous Thrombosis
Cushman, M. (2007) · Seminars in Hematology · doi:10.1053/j.seminhematol.2007.02.004 · Cited by 755
“For example, in two recent studies of long-term anticoagulation after an episode of venous thrombosis, higher D-dimer assessed after completion of an initial course of anticoagulation was associated with an increased risk of recurrent thrombosis, and this risk was lowered in those maintained on long-term anticoagulati…”
BackgroundO’Donnell, T. F., Passman, M. A., Marston, W. A., Ennis, W. J., Dalsing, M., Kistner, R. L., Lurie, F., Henke, P. K., Gloviczki, M. L., Eklöf, B. G., et al. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.04.049 · Cited by 720
D-dimer antigen: current concepts and future prospects
Adam, S. S., Key, N. S., & Greenberg, C. S. (2009) · Blood · doi:10.1182/blood-2008-06-165845 · Cited by 668
Weitz, J. I., Fredenburgh, J. C., & Eikelboom, J. W. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.024 · Cited by 582
Rodger, M. A., Kahn, S. R., Wells, P. S., Anderson, D. A., Chagnon, I., Le Gal, G., Solymoss, S., Crowther, M., Perrier, A., White, R., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080493 · Cited by 581
“Only the use of D-dimer levels as a predictor variable has been studied in a prospective management study.(24) In this study, a normal D-dimer value after stopping oral anticoagulants was not sufficient to identify patients at low risk (i.”
BackgroundMethodRisk factors for venous and arterial thrombosis.
Previtali, E., Bucciarelli, P., Passamonti, S. M., & Martinelli, I. (2011) · PubMed · doi:10.2450/2010.0066-10 · Cited by 447
TOSETTO, A., IORIO, A., MARCUCCI, M., BAGLIN, T., CUSHMAN, M., EICHINGER, S., PALARETI, G., POLI, D., TAIT, R. C., & DOUKETIS, J. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04735.x · Cited by 443
Self-citationAy, C., Vormittag, R., Dunkler, D., Simanek, R., Chiriac, A.-L., Drach, J., Quehenberger, P., Wagner, O., Zielinski, C., & Pabinger, I. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7752 · Cited by 422
Respiratory follow-up of patients with COVID-19 pneumonia
George, P. M., Barratt, S. L., Condliffe, R., Desai, S. R., Devaraj, A., Forrest, I., Gibbons, M. A., Hart, N., Jenkins, R. G., McAuley, D. F., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-215314 · Cited by 390
Mechanisms of Venous Thrombosis and Resolution
Wakefield, T. W., Myers, D. D., & Henke, P. K. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.162289 · Cited by 393
Johnson, E. D., Schell, J. C., & Rodgers, G. M. (2019) · American Journal of Hematology · doi:10.1002/ajh.25482 · Cited by 303
“as part of a diagnostic model/paradigm, for example, in exclusion of VTE and in determining duration of anticoagulation.(13,14) Despite this”
MethodHigh D-dimer levels are associated with poor prognosis in cancer patients
Ay, C., Dunkler, D., Pirker, R., Thaler, J., Quehenberger, P., Wagner, O., Zielinski, C., & Pabinger, I. (2012) · Haematologica · doi:10.3324/haematol.2011.054718 · Cited by 340
“In a prospective, interventional study in patients without cancer who had unprovoked VTE and who had received vitamin K antagonists, D-dimer levels were measured 1 month after discontinuation of anticoagulation to determine the duration of anticoagulation therapy, suggesting a prolonged anticoagulation for prevention…”
BackgroundThrombin Generation Assay and Its Application in the Clinical Laboratory
Tripodi, A. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.248625 · Cited by 318
Self-citationRisk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D., Tait, R. C., & Iorio, A. (2011) · BMJ · doi:10.1136/bmj.d813 · Cited by 278
Self-citationDuration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
Kearon, C., & Akl, E. A. (2014) · Blood · doi:10.1182/blood-2013-12-512681 · Cited by 279
Verhovsek, M., Douketis, J. D., Yi, Q., Shrivastava, S., Tait, R. C., Baglin, T., Poli, D., & Lim, W. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-7-200810070-00008 · Cited by 264
Klings, E. S., Machado, R. F., Barst, R. J., Morris, C. R., Mubarak, K. K., Gordeuk, V. R., Kato, G. J., Ataga, K. I., Gibbs, J. S., Castro, O., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0065st · Cited by 263
Risk assessment for recurrent venous thrombosis
Kyrle, P. A., Rosendaal, F. R., & Eichinger, S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60962-2 · Cited by 261
Biomarkers for prediction of venous thromboembolism in cancer
Pabinger, I., Thaler, J., & Ay, C. (2013) · Blood · doi:10.1182/blood-2013-04-460147 · Cited by 256
“This usefulness of D-dimer for the management of VTE patients was already demonstrated in an interventional trial in noncancer patients.(92) Combining D-dimer with other routinely available biomarkers, such as platelets, leukocytes, or hemoglobin, and with clinical parameters (eg, tumor type) would provide an easy-to-…”
BackgroundPrandoni, P., Prins, M. H., Lensing, A. W. A., Ghirarduzzi, A., Ageno, W., Imberti, D., Scannapieco, G., Ambrosio, G. B., Pesavento, R., Cuppini, S., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00003 · Cited by 232
Self-citationGeersing, G. J., Zuithoff, N. P. A., Kearon, C., Anderson, D. R., ten Cate-Hoek, A. J., Elf, J. L., Bates, S. M., Hoes, A. W., Kraaijenhagen, R. A., Oudega, R., et al. (2014) · BMJ · doi:10.1136/bmj.g1340 · Cited by 227
Douketis, J. D., Gu, C. S., Schulman, S., Ghirarduzzi, A., Pengo, V., & Prandoni, P. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-11-200712040-00007 · Cited by 220
“Clinical outcomes occurring during follow-up, n (%) All events 501 (24) 374 (23) 127 (30) Nonfatal DVT 340 (68) 241 (64) 99 (78) Nonfatal pulmonary embolism 116 (23) 95 (25) 21 (17) Possible fatal pulmonary embolism (undetermined cause of sudden death) 27 (5) 27 (7) 0 (0)”
BackgroundSelf-citationD-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications
Favresse, J., Lippi, G., Roy, P.-M., Chatelain, B., Jacqmin, H., ten Cate, H., & Mullier, F. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1529734 · Cited by 212
BAGLIN, T., DOUKETIS, J., TOSETTO, A., MARCUCCI, M., CUSHMAN, M., KYRLE, P., PALARETI, G., POLI, D., TAIT, R. C., & IORIO, A. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04022.x · Cited by 214
Self-citationVenous Thromboembolism: Risk Factors for Recurrence
Zhu, T., Martinez, I., & Emmerich, J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.182428 · Cited by 210
TRIPODI, A., LEGNANI, C., CHANTARANGKUL, V., COSMI, B., PALARETI, G., & MANNUCCI, P. M. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03018.x · Cited by 196
Self-citationSiragusa, S., Malato, A., Anastasio, R., Cigna, V., Milio, G., Amato, C., Bellisi, M., Attanzio, M. T., Cormaci, O., Pellegrino, M., et al. (2008) · Blood · doi:10.1182/blood-2008-01-131656 · Cited by 196
d-Dimer Testing in Laboratory Practice
Tripodi, A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.166249 · Cited by 192
“Palareti 등[25]은 항응고제 치료의 최적 기간을 결정하는데 D-dimer 검사 의 이용에 대하여 보고하였다.”
Self-citation(2015) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2014.12.001 · Cited by 186
BESSER, M., BAGLIN, C., LUDDINGTON, R., VAN HYLCKAMA VLIEG, A., & BAGLIN, T. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03117.x · Cited by 191
Palareti, G., Cosmi, B., Legnani, C., Antonucci, E., De Micheli, V., Ghirarduzzi, A., Poli, D., Testa, S., Tosetto, A., Pengo, V., et al. (2014) · Blood · doi:10.1182/blood-2014-01-548065 · Cited by 190
“DVT 16 (14) 8 (6) 1 PE 5 (5) 3 (3) 2 (1) DVT1PE 4 (3) 4 (2) 1”
Self-citationGuideline on the investigation, management and prevention of venous thrombosis in children*
Chalmers, E., Ganesen, V., Liesner, R., Maroo, S., Nokes, T., Saunders, D., & Williams, M. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08543.x · Cited by 188
“The persistence of elevated levels of D-Dimer has been shown in adults to be related to recurrence of thrombosis (Palareti et al, 2002; Palareti et al, 2006; Eichinger et al, 2003) and has been proposed as an indication for prolongation of anticoagulation, though such a proposal remains…”
BackgroundNicolaides, A., Fareed, J., Kakkar, A. K., Comerota, A. J., Goldhaber, S. Z., Hull, R., Myers, K., Samama, M., Fletcher, J., Kalodiki, E., et al. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612474840 · Cited by 185
Thrombotic risk factors: Basic pathophysiology
Martinelli, I., Bucciarelli, P., & Mannucci, P. M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c9cbd9 · Cited by 177
Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cushman, M., Eichinger, S., Palareti, G., Poli, D., Tait, R. C., & Iorio, A. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-8-201010190-00009 · Cited by 175
“For the 2 trials in which some patients with a positive D-dimer result were randomly allocated to resume anticoagulation (16, 17), such patients were excluded from the analyses.”
BackgroundMethodInfluentialSelf-citationVan Hylckama Vlieg, A., Christiansen, S. C., Luddington, R., Cannegieter, S. C., Rosendaal, F. R., & Baglin, T. P. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06738.x · Cited by 171
“Palareti et al (2006) demonstrated that D-dimer testing could be used in the identification of individuals less prone to recurrent venous thrombosis.”
BackgroundFibrinolysis and Inflammation in Venous Thrombus Resolution
Mukhopadhyay, S., Johnson, T. A., Duru, N., Buzza, M. S., Pawar, N. R., Sarkar, R., & Antalis, T. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01348 · Cited by 164
“In clinical cases, the majority of the patients have reduced D-dimer level present in the circulation 1 month after the first episode of DVT (85).”
BackgroundKlok, F. A., Zondag, W., van Kralingen, K. W., van Dijk, A. P. J., Tamsma, J. T., Heyning, F. H., Vliegen, H. W., & Huisman, M. V. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1141oc · Cited by 163
Coagulopathy and embolic signal in cancer patients with ischemic stroke
Seok, J. M., Kim, S. G., Kim, J. W., Chung, C., Kim, G., Lee, K. H., & Bang, O. Y. (2010) · Annals of Neurology · doi:10.1002/ana.22050 · Cited by 162
“It could be difficult to definitively attribute a stroke mechanism to hypercoagulability based on D-dimers alone.(7,20) We could not preclude this possibility, because the effect of treatment and complications of cancers such as infection were not considered in this study.”
BackgroundIntroduction to the Ninth Edition
Guyatt, G. H., Akl, E. A., Crowther, M., Schünemann, H. J., Gutterman, D. D., & Lewis, S. Z. (2012) · Chest · doi:10.1378/chest.11-2286 · Cited by 159
Biomarkers and Venous Thromboembolism
Pabinger, I., & Ay, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.182188 · Cited by 158
Cosmi, B., Legnani, C., Tosetto, A., Pengo, V., Ghirarduzzi, A., Testa, S., Prisco, D., Poli, D., Tripodi, A., Marongiu, F., et al. (2009) · Blood · doi:10.1182/blood-2009-08-237354 · Cited by 150
Self-citationThe controversy of managing calf vein thrombosis
Masuda, E. M., Kistner, R. L., Musikasinthorn, C., Liquido, F., Geling, O., & He, Q. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.05.092 · Cited by 149
Kearon, C., Spencer, F. A., O’Keeffe, D., Parpia, S., Schulman, S., Baglin, T. P., Stevens, S. M., Kaatz, S., Bauer, K. A., Douketis, J. D., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1275 · Cited by 154
Khan, F. A., Tritschler, T., Kimpton, M., Wells, P. S., Kearon, C., Weitz, J. I., Buller, H. R., Raskob, G. E., Ageno, W., Couturaud, F., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-1094 · Cited by 152
Self-citationCampbell, I. A., Bentley, D. P., Prescott, R. J., Routledge, P., Shetty, H. G. M., & Williamson, I. J. (2007) · BMJ · doi:10.1136/bmj.39098.583356.55 · Cited by 155
Galanaud, J. ‐., Sevestre, M., Genty, C., Kahn, S. R., Pernod, G., Rolland, C., Diard, A., Dupas, S., Jurus, C., Diamand, J. M., et al. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12512 · Cited by 140
Prediction of Recurrent Venous Thromboembolism by Endogenous Thrombin Potential and D-Dimer
Eichinger, S., Hron, G., Kollars, M., & Kyrle, P. A. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.112243 · Cited by 134
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Middeldorp, S., Prins, M. H., & Hutten, B. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001367.pub3 · Cited by 133
D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding Disorders
Bates, S. M. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1326782 · Cited by 131
Pulmonary embolism: risk assessment and management
Konstantinides, S., & Goldhaber, S. Z. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs258 · Cited by 130
“An alternative approach would be to interrupt treatment for 1 month and then resume anticoagulation (only) if the D-dimer test is positive.(107) Finally, although one study indicated that CTEPH may develop in as many as 3.”
BackgroundGUIDELINES ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE PULMONARY EMBOLISM
Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., Bengel, F. M., Brady, A. J. B., Ferreira, D., Janssens, U., et al. (2009) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2009-5-1-96-111 · Cited by 130
Thrombophilia: Common Questions on Laboratory Assessment and Management
Heit, J. A. (2007) · Hematology · doi:10.1182/asheducation-2007.1.127 · Cited by 131
“An increased D-dimer measured at least 1 month after stopping warfarin therapy may be a predictor of recurrence independent of residual venous obstruction.(30,31) Secondary prophylaxis with anticoagulation therapy should be considered for patients with the above-described characteristics.”
BackgroundUse of anticoagulants in elderly patients: practical recommendations
Righini, M. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s4308 · Cited by 133
“2% over 18 months compared to 15% for patients with D-dimer 500 μg/L).(17) However, this interesting fi nding does not seem applicable to the elderly in order to identify lower risk patients because the probability of having normal D-dimer level in this population is low.”
Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment
Tripodi, A., de Groot, P. G., & Pengo, V. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02362.x · Cited by 125
Self-citationLechner, D., Wiener, C., Weltermann, A., Eischer, L., Eichinger, S., & Kyrle, P. A. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02998.x · Cited by 111
An update on etiology, prevention, and therapy of postthrombotic syndrome
Henke, P. K., & Comerota, A. J. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.08.050 · Cited by 108
Poli, D., Grifoni, E., Antonucci, E., Arcangeli, C., Prisco, D., Abbate, R., & Miniati, M. (2010) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-010-0452-x · Cited by 110
Napolitano, M., Saccullo, G., Malato, A., Sprini, D., Ageno, W., Imberti, D., Mascheroni, D., Bucherini, E., Gallucci, P., D’Alessio, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.7433 · Cited by 113
“• <zjss;Cancer-Related Complications> negative D-dimer test may support the safe withdrawal of VKA from 3 to 6 months after DVT.10 Conversely, RVT has been associated with an increased risk for recurrent VTE in both idiopathic and provoked DVT.11-13 In comparison to the D-dimer, RVT is not influenced by factors acting…”
BackgroundSelf-citationSerum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications
Pasini, E., Corsetti, G., Romano, C., Scarabelli, T. M., Chen-Scarabelli, C. A., Saravolatz, L. I. I., & Dioguardi, F. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.714426 · Cited by 116
“Therefore, DD are involved in coagulation cascade and its increase in the blood is a marker of hypercoagulability (39).”
BackgroundTan, M., Mol, G. C., van Rooden, C. J., Klok, F. A., Westerbeek, R. E., del Sol, A. I., van de Ree, M. A., Roos, A., & Huisman, M. V. (2014) · Blood · doi:10.1182/blood-2014-04-566380 · Cited by 103
“Although this indeed is a strong argument for the absence of acute DVT, higher D-dimer levels are common in asymptomatic patients after completion of a 6-month treatment period for acute venous thromboembolism (VTE) and are associatedwithmore extensive residual thrombosis as well as a higher recurrence risk.(17,18) He…”
Vlieg, A. V. H., Baglin, C., Luddington, R. J., MacDonald, S. G., Rosendaal, F. R., & Baglin, T. P. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13043 · Cited by 105
Venous thrombosis in the elderly: more questions than answers
Silverstein, R. L., Bauer, K. A., Cushman, M., Esmon, C. T., Ershler, W. B., & Tracy, R. P. (2007) · Blood · doi:10.1182/blood-2007-06-096545 · Cited by 96
Eichinger, S., Heinze, G., & Kyrle, P. A. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000467 · Cited by 99
“According to another Italian study, the high risk of recurrence of patients with abnormal D-dimer after discontinuation of anticoagulation can be substantially reduced by extending anticoagulation.(11) To further improve risk assessment of recurrent VTE,”
BackgroundHelp me, Doctor! My D-dimer is raised
Lippi, G., Franchini, M., Targher, G., & Favaloro, E. J. (2008) · Annals of Medicine · doi:10.1080/07853890802161015 · Cited by 94
“The risk of recurrence in patients with normal D-dimer is significantly lower (67).”
BackgroundBecattini, C., Vedovati, M. C., Ageno, W., Dentali, F., & Agnelli, G. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03777.x · Cited by 94
Bruinstroop, E., Klok, F. A., van de Ree, M. A., OOSTERWIJK, F. L., & Huisman, M. V. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03293.x · Cited by 90
Gianesini, S., Obi, A. T., Onida, S., Baccellieri, D., Bissacco, D., Борсук, Д. А., Campisi, C., Campisi, C. C., Cavezzi, A., Chi, Y., et al. (2019) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355519870690 · Cited by 99
Thrombophilia screening revisited: an issue of personalized medicine
Colucci, G., & Tsakiris, D. Α. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02090-y · Cited by 90
Liu, L., & Ji, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-17293-4_11 · Cited by 84
How I treat the antiphospholipid syndrome
Giannakopoulos, B., & Krilis, S. A. (2009) · Blood · doi:10.1182/blood-2009-05-220756 · Cited by 91
The current role and future prospects of D-dimer biomarker
Soomro, A., Guerchicoff, A., Nichols, D. J., Suleman, J., & Dangas, G. (2015) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvv039 · Cited by 80
“Palareti and colleagues(20) assessed serum D-dimer levels in patients who had suffered a first time, unprovoked, proximal DVT or PE.”
the SOX Trial Investigators, Kahn, S. R., Shbaklo, H., Shapiro, S., Wells, P. S., Kovacs, M. J., Rodger, M. A., Anderson, D. R., Ginsberg, J. S., Johri, M., et al. (2007) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-7-21 · Cited by 80
“Recent work performed by our group and by others suggests that D-dimer levels appear to be a significant predictor of first VTE [22] and of recurrent VTE [23-28], whether measured during or after anticoagulation.”
How to use D-dimer in acute cardiovascular care
Giannitsis, E., Mair, J. M., Christersson, C., Siegbahn, A. G., Huber, K., Jaffe, A. S., Peacock, W. F., Plebani, M., Thygesen, K. A., Möckel, M., et al. (2015) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872615610870 · Cited by 81
Grau, E., Tenías, J. M., Soto, M. J., Gutierrez, M. R., Lecumberri, R., Pérez, J. L., & Tiberio, G. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000277044.25556.93 · Cited by 78
“Furthermore, a recent prospective study reported that high Ddimer levels performed after withdrawal of oral anticoagulant therapy in patients with deep vein thrombosis (DVT) or PE have a significant incidence of recurrent VTE that is reduced by the resumption of anticoagulation (14).”
BackgroundShould Patients with Venous Thromboembolism Be Screened for Thrombophilia?
Dalen, J. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.10.042 · Cited by 78
Uresandi, F., Monréal, M., García-Bragado, F., Domenech, P., Lecumberri, R., Escribano, P., Zamorano, J. L., Jiménez, S., Ruiz‐Artacho, P., Lozano, F., et al. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2013.07.008 · Cited by 94
Cohen, H., Doré, C. J., Clawson, S., Hunt, B. J., Isenberg, D., Khamashta, M. A., & Muirhead, N. (2015) · Lupus · doi:10.1177/0961203315581207 · Cited by 81
O’Donnell, T. F., & Passman, M. A. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.04.058 · Cited by 83
Fisser, C., Reichenbächer, C., Müller, T. M., Schneckenpointner, R., Malfertheiner, M. V., Philipp, A., Foltan, M., Lunz, D., Zeman, F., & Lubnow, M. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003650 · Cited by 76
Marcucci, M., Iorio, A., Douketis, J. D., Eichinger, S., Tosetto, A., Baglin, T. P., Cushman, M., Palareti, G., Poli, D., Tait, R. C., et al. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12871 · Cited by 76
Self-citationCosmi, B., Nijkeuter, M., Valentino, M., Huisman, M. V., Barozzi, L., & Palareti, G. (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0577-8 · Cited by 71
Self-citationEffect of Low-Dose Aspirin on the Occurrence of Venous Thromboembolism
Glynn, R. J., Ridker, P. M., Goldhaber, S. Z., & Buring, J. E. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00004 · Cited by 71
Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines
Min, S., Kim, Y. H., Joh, J. H., Kang, J. M., Park, U. J., Kim, H.-K., Chang, J.-H., Park, S. J., Kim, J. Y., Bae, J. I., et al. (2016) · Vascular Specialist International · doi:10.5758/vsi.2016.32.3.77 · Cited by 77
Metadata
- Authors
- Palareti, G., Cosmi, B., Legnani, C., Tosetto, A., Brusi, C., Iorio, A., Pengo, V., Ghirarduzzi, A., Pattacini, C., Testa, S., Lensing, A. W. A., & Tripodi, A.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Ospedale San Bortolo (IT)
- University of Perugia (IT)
- Azienda Ospedale - Università Padova (IT)
- Santa Maria Nuova Hospital (IT)
- Istituti Ospitalieri di Cremona (IT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-10-26
- Volume
- 355
- Issue
- 17
- Pages
- 1780-1789
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2047986798
- Cited by
- 622
- References
- 25
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 12 · 2023: 11 · 2022: 14 · 2021: 16 · 2020: 34 · 2019: 22 · 2018: 20 · 2017: 19 · 2016: 40 · 2015: 41 · 2014: 40 · 2013: 38 · 2012: 53
- FWCI
- 35.51
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
- Keywords
- D-dimer, anticoagulation duration, venous thromboembolism, deep vein thrombosis, pulmonary embolism, vitamin K antagonists, recurrence, major bleeding, unprovoked thrombosis, anticoagulation resumption
- MeSH terms
- Acenocoumarol, Adult, Aged, Aged, 80 and over, Anticoagulants, Antithrombins, Drug Administration Schedule, Fibrin Fibrinogen Degradation Products, Follow-Up Studies, Hemorrhage, Humans, Middle Aged, Prospective Studies, Pulmonary Embolism, Recurrence, Ultrasonography, Vitamin K, Warfarin, Proportional Hazards Models, Survival Analysis, Antiphospholipid Syndrome, Venous Thrombosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.